Characterization of the molecular mechanisms of Epstein-Barr Virus-mediated inhibition of the innate sensor TLR9

Characterization of the molecular mechanisms of Epstein-Barr Virus-mediated inhibition of the innate sensor TLR9

L’infection chronique est à l’origine de 15-20% des cancers dans le monde. Dans la plupart des cas, les infections sont éliminées par le système immunitaire, sans incidence importante sur les hôtes infectés. Toutefois, les oncovirus peuvent échapper au système immunitaire et induire une transformati...

Full description

Bibliographic Details
Main Author:	Fathallah, Ikbal
Other Authors:	Lyon 1
Language:	en
Published:	2009
Subjects:	TLR9 LMP1 Réponse immunitaire innée EBV Innate immune response 616.994
Online Access:	http://www.theses.fr/2009LYO10323

Similar Items

Modulation of the innate immune response by the oncoviruses EBV and HPV
by: Parroche, Peggy
Published: (2011)

Characterization of a Suppressive Cis-acting Element in the Epstein–Barr Virus LMP1 Promoter
by: Masahiro Yoshida, et al.
Published: (2017-11-01)

Rôle des variants de la protéine de latence LMP du virus d'Epstein-Barr dans le développement du lymphome de Hodgkin chez les personnes VIH+
by: Sueur, Charlotte
Published: (2013)

Co-Expression of the Epstein-Barr Virus-Encoded Latent Membrane Proteins and the Pathogenesis of Classic Hodgkin Lymphoma
by: Katerina Vrzalikova, et al.
Published: (2018-08-01)

CRISPR/Cas9-mediated LMP1 knockout inhibits Epstein-Barr virus infection and nasopharyngeal carcinoma cell growth
by: Haifeng Huo, et al.
Published: (2019-10-01)

Epstein-Barr Virus and Classical Hodgkin’s Lymphoma
by: VE Gurtsevich
Published: (2016-04-01)

The role of toll-like receptor 9 (TLR9) in Epstein-Barr virus-associated gastric cancer
by: Dworzanska Anna, et al.
Published: (2020-06-01)

LMP1 and LMP2A are potential prognostic markers of extranodal NK/T-cell lymphoma, nasal type (ENKTL)
by: Mao Yuan, et al.
Published: (2012-12-01)

Serum and Tissue Level of TLR9 in EBV-Associated Oropharyngeal Cancer
by: Ewa Stępień, et al.
Published: (2021-08-01)

Analysis of EBNA-1 and LMP-1 variants in diseases associated with EBV infection in Chinese children
by: Ai Junhong, et al.
Published: (2012-01-01)

A Systematic Review of Epstein–Barr Virus Latent Membrane Protein 1 (LMP1) Gene Variants in Nasopharyngeal Carcinoma
by: Ana Banko, et al.
Published: (2021-08-01)

Epstein–Barr Virus LMP1 Induces Soluble PD-L1 in Nasopharyngeal Carcinoma
by: Kina Kase, et al.
Published: (2021-03-01)

Generation and Characterization of a Novel Recombinant Antibody against LMP1-TES1 of Epstein-Barr Virus Isolated by Phage Display
by: Jin Zhu, et al.
Published: (2013-04-01)

Investigação da LMP1 do EBV e a coinfeçcão do HPV em lesões genitais de pacientes infectados ou não pelo HIV Investigation of the LMP1 EBV and co-infection by HPV in genital lesions of patients infected or not by HIV
by: Fabiana Resende Rodrigues, et al.
Published: (2010-10-01)

Role of Epstein–Barr Virus C Promoter Deletion in Diffuse Large B Cell Lymphoma
by: Seiyo Mabuchi, et al.
Published: (2021-02-01)

Ekspresi produk gen laten virus epstein-barr pada karsinoma sel skuamosa rongga mulut (The expressions of latent gene product of epstein-barr virus in oral squamous cell carcinoma)
by: Theresia Indah Budhy S
Published: (2005-06-01)

EBV‐LMP1 induces APOBEC3s and mitochondrial DNA hypermutation in nasopharyngeal cancer
by: Kousho Wakae, et al.
Published: (2020-10-01)

CD137 Co-Stimulation Improves The Antitumor Effect Of LMP1-Specific Chimeric Antigen Receptor T Cells In Vitro And In Vivo
by: Tang X, et al.
Published: (2019-11-01)

Serum EBV antibodies and LMP-1 in Polish patients with oropharyngeal and laryngeal cancer
by: Sylwia Fołtyn, et al.
Published: (2017-05-01)

PRESENCIA DEL MARCADOR LMP-1 DEL VIRUS EPSTEIN-BARR EN LINFOMAS DE CANINOS
by: L. C. Veloza, et al.
Published: (2017-01-01)

Sequence variation of latent membrane protein 2A (LMP2A)gene from Epstein-Barr virus epitope cytotoxic T-lymphocyte (CTL)related to human leucocyte antigen-A24 (HLA-A24)in peripheral blood sample and cytobrushof nasopharyngeal cancer patients
by: Maya Esther Wullur Moningka, et al.
Published: (2019-07-01)

Temporal Regulation of LMP1 and Apoptosis Resistance After Primary EBV Infection
by: Price, Alexander Matthew
Published: (2016)

The EBV-Encoded Oncoprotein, LMP1, Recruits and Transforms Fibroblasts via an ERK-MAPK-Dependent Mechanism
by: Alexandra M Davis, et al.
Published: (2021-08-01)

Spleen Tyrosine Kinase Inhibitor TAK-659 Prevents Splenomegaly and Tumor Development in a Murine Model of Epstein-Barr Virus-Associated Lymphoma
by: Osman Cen, et al.
Published: (2018-08-01)

Extranodal NK/T-Cell Lymphoma, Nasal Type: Genetic, Biologic, and Clinical Aspects with a Central Focus on Epstein–Barr Virus Relation
by: Miki Takahara, et al.
Published: (2021-06-01)

The Expression of mRNA LMP1 Epstein-Barr Virus from FFPE Tumour Biopsy: a Potential Biomarker of Nasopharyngeal Carcinoma Diagnosis
by: Daniel Joko Wahyono, et al.
Published: (2017-07-01)

Role of Epstein–Barr Virus in the Pathogenesis of Head and Neck Cancers and Its Potential as an Immunotherapeutic Target
by: Queenie Fernandes, et al.
Published: (2018-07-01)

Comparison of TGF-β, IL-10 levels and LMP-1 in gastric and oropharyngeal carcinoma associated with EBV infection
by: Dworzanska Anna, et al.
Published: (2019-12-01)

The Anti-Apoptotic Role of EBV-LMP1 in Lymphoma Cells
by: Zeng M, et al.
Published: (2020-09-01)

Libération extra-cellulaire de microARN et de complexes nucléo-protéiques par les cellules infectées par EBV : rôle des exosomes et d’autres transporteurs
by: Gourzones, Claire
Published: (2011)

The role of Toll-like receptors (TLRs) in virus-related cancers: a mini review
by: Dworzanska Anna, et al.
Published: (2020-12-01)

Novel Synthetic DNA Immunogens Targeting Latent Expressed Antigens of Epstein–Barr Virus Elicit Potent Cellular Responses and Inhibit Tumor Growth
by: Krzysztof Wojtak, et al.
Published: (2019-05-01)

Latent membrane protein 1 (LMP1) expression in Hodgkin lymphoma and its correlation with clinical and histologic parameters
by: Atif Ali Hashmi, et al.
Published: (2017-04-01)

Analysis of a structured intronic region of the LMP2 pre-mRNA from EBV reveals associations with human regulatory proteins and nuclear actin
by: Nuwanthika Kumarasinghe, et al.
Published: (2019-01-01)

Caractérisation du rôle de BAD-LAMP comme chaperonne des "Toll like receptors" au sein des cellules dendritiques plasmacytoïdes humaines
by: Combes, Alexis
Published: (2016)

Dysregulation of CD40 signaling pathways in enhanced B cell activation and autoimmunity
by: Peters, Anna Louisa
Published: (2011)

Aberrant antigenic expression in extranodal NK/T-cell lymphoma: a multi-parameter study from Thailand
by: Pongpruttipan Tawatchai, et al.
Published: (2011-08-01)

Co-expression of low-risk HPV E6/E7 and EBV LMP-1 leads to precancerous lesions by DNA damage
by: Karina Uehara, et al.
Published: (2021-06-01)

Molecular Interactions between Two LMP2A PY Motifs of EBV and WW Domains of E3 Ubiquitin Ligase AIP4
by: Min-Duk Seo, et al.
Published: (2021-04-01)

Role of Epstein-Barr virus in the development of nasopharyngeal carcinoma
by: Zhang Hui, et al.
Published: (2017-06-01)

Cannot write session to /tmp/vufind_sessions/sess_b3rquluallegc009kfg1ipirce